Oppenheimer Upgrades Outlook on Marvell Technology With Price Target Boost Safepoint Insurance Targets 116 Billion Valuation in US IPO Analysts Suggest Broader Policy Shift Beyond Weaker Dollar to Aid US Manufacturing Consumer Credit Growth Accelerates in December Signaling Robust Consumer Spending Gold Faces Second Weekly Decline as OilDriven Inflation Concerns Spur Rate Hike Expectations The Hidden Cost of Lifestyle Creep Why Higher Earnings Dont Always Mean Financial Security Mid Penn Bancorp MPB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Quarter ZURA Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage Dominari Holdings Inc DOMH Q1 2024 Earnings Reports GAAP Loss of 035 Per Share Amid Flat Revenue GSK Q1 2026 Earnings EPS Beats Estimates Amid Revenue Data Gap BMY Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline and Pipeline Advances Chicago Atlantic BDC Inc LIEN Q1 2026 Earnings EPS Surpasses Estimates by 2168 Signaling Strong Portfolio Performance Laureate Education LAUR Edges Lower as Resistance Holds Near Support Regal Rexnord RRX Tests Key Resistance as Shares Rally 224 Roman DBDR Acquisition Corp II Warrants DRDBW Slide 1157 as Price Nears Support Level RenaissanceRe Holdings RNR Shows Modest Decline Amid Stable Trading Support and Resistance Levels in Focus Prothena PRTA Edges Lower Near Support as Biotech Sector Faces Headwinds Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Blocker Effects TTEC Q1 2026 Earnings EPS Miss Amid Operational Headwinds MINISO MNSO Slides 378 as Bears Test Key Support Near 1185 Bitcoin Depot Inc BTM Q4 2025 Earnings Massive EPS Miss of 826 Per Share Stock Declines 15 BMBL Q1 2026 Earnings EPS Surges Past Estimates with 224 Beat FRPH Q4 2024 Earnings Modest Earnings Amid Stock Decline ASP Isotopes Q4 2025 Earnings Widerthanexpected loss fails to dampen investor sentiment ABCL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction AVR Q1 2026 Earnings Wider Than Expected Losses as PreRevenue Biotech Advances REZI Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty Stock Slides